COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors

OBJECTIVE: COVID19 has caused a global and ongoing pandemic. The need for population seroconversion data is apparent to monitor and respond to the pandemic. Using a lateral flow assay (LFA) testing platform, the seropositivity in 63 New York Blood Center (NYBC) Convelescent Plasma (CP) donor samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragnesola, Brett, Jin, Daniel, Lamb, Christopher C., Shaz, Beth H., Hillyer, Christopher D., Luchsinger, Larry L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407441/
https://www.ncbi.nlm.nih.gov/pubmed/32762746
http://dx.doi.org/10.1186/s13104-020-05212-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407441/
https://www.ncbi.nlm.nih.gov/pubmed/32762746
http://dx.doi.org/10.1186/s13104-020-05212-0

Ejemplares similares